I

iRadimed Corp
D

IRMD

56.200
USD
-1.03
(-1.80%)
Market Closed
Volume
1,570
EPS
2
Div Yield
0.8
P/E
38
Market Cap
712,247,384
Related Instruments
    C
    CRL
    0.770
    (0.47%)
    163.120 USD
    E
    EXAS
    -0.270
    (-0.55%)
    49.250 USD
    G
    GH
    -4.510
    (-9.51%)
    42.910 USD
    G
    GMED
    -3.810
    (-4.53%)
    80.280 USD
    I
    IRBT
    -0.75500
    (-7.94%)
    8.75000 USD
    P
    PODD
    -5.82
    (-2.02%)
    282.56 USD
    Q
    QGEN
    1.010
    (2.62%)
    39.570 USD
    R
    RBC
    -11.34
    (-3.08%)
    357.24 USD
    SYK
    SYK
    -3.72
    (-0.96%)
    382.74 USD
    More
News

Title: iRadimed Corp

Sector: Healthcare
Industry: Medical Devices
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.